Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

ClinicalTrials.gov ID: NCT02991430

Public ClinicalTrials.gov record NCT02991430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02991430
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Scion NeuroStim
Industry
Enrollment
45 participants

Conditions and interventions

Conditions

Interventions

  • active neuromodulation for episodic migraine headache Device
  • placebo neuromodulation for episodic migraine headache Device

Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2017
Primary completion
May 10, 2018
Completion
May 10, 2018
Last update posted
Jun 18, 2019

2017 – 2018

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259
Neurology Research Institute West Palm Beach Florida 33407
Diamond Headache Clinic Chicago Illinois 60642
Michigan Headache Pain & Neurological Inst. Ann Arbor Michigan 48104
Study Metrix Research City of Saint Peters Missouri 63303
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Cleveland Clinic Cleveland Ohio 44195
Jefferson Headache Center Philadelphia Pennsylvania 19107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02991430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02991430 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →